Targeted Strategies for Today's Evolving Markets

MissionIR Blog

New Clinical Data Further Supports Chromium Picolinate’s Ability to Enhance Brain Activity in Older Adults – Study Used Key Ingredient in Nutrition 21’s (NASDAQ: NXXI) Core4Life Advanced Memory Formula™

Nutrition 21, Inc. (NASDAQ: NXXI), a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research, announced the results of a chromium picolinate study that confirmed that daily receiving chromium 1000 mcg supplementation as chromium picolinate increased brain activity in older adults experiencing early-stage memory loss. The results of this study were presented at the 19th annual meeting of the American Neuropsychiatric Association.

Researchers utilized Nutrition 21’s proprietary chromium picolinate found in Core4Life Advanced Memory Formula™ for their study. Core4Life Advanced Memory Formula contains chromium picolinate, phosphatidylserine (PS) and DHA, which have been scientifically tested for their ability to improve cognitive function, promote healthy blood sugar levels and help maintain cognitive function.

Nutrition 21 focuses on researching and developing products that are marketed under the Dietary Supplement Health and Education Act (DSHEA) This regulatory pathway through the Food and Drug Administration (FDA) allows companies to bring products to the market faster and with less cost than a standard FDA drug approval.

Nutrition 21 portfolio of health and wellness brands include: Chromax®, Core4Life Advanced Memory Formula™, Diabetes Essentials™, Iceland Health® Maximum Strength Omega-3 and Iceland Health® Joint Relief.

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *